CHI3L1 and Hypertension: To test this hypothesis we quantified plasma levels of YKL-40 in OSA patients matched for age and co-morbidities with and without hypertension and compared these values to measures of endothelial function by assessing flow-mediated nitric oxide-dependent vasodilatory capacity.